Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belatacept for the Management of Moderately Sensitized Patients at Risk for Delayed Graft Function (DGF)

NCT02130817 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT02130817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belatacept for the Management of Moderately Sensitized Patients at Risk for Delayed Graft Function (DGF)
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 4
Overall status
Withdrawn
Start date
September 24, 2014
Completion date
October 9, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody mediated rejection, end stage renal disease